CFF Pilot and Feasibility Award
Backs research teams and institutions for CFF Pilot and Feasibility Award in biotechnology and medical technology.
The Cystic Fibrosis Foundation Pilot and Feasibility Award supports investigators who wish to test new scientific hypotheses relevant to cystic fibrosis without requiring substantial preliminary data. The program is intended as an entry point for researchers new to the CF field or for established investigators exploring a novel direction not yet supported by extensive prior work. Awards provide $50,000 per year for up to two years, with a 12% indirect cost allowance applied to direct costs.
Applications are accepted twice per year, with deadlines in May and December. Proposals are reviewed by the Foundation's Research and Research Training (RRT) Committee, which applies a peer-review process modeled on the NIH system. The typical timeline from submission to funding notification runs four to eight months. All applications are submitted through the CFF grants management portal at awards.cff.org.
Eligibility is open to investigators at academic institutions conducting research relevant to cystic fibrosis biology, treatment, or care. The program sits within CFF's broader academic funding portfolio, which ranges from pilot awards through large collaborative research grants. The Pilot and Feasibility Award is explicitly not restricted to investigators pursuing the Foundation's Path to a Cure gene therapy priority; basic and translational science outside that priority area is eligible under the standard track.
Novel basic-science hypotheses in cystic fibrosis etiology and pathogenesis outside the PTAC gene therapy priority, designed to generate preliminary data without requiring substantial existing evidence.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline